CRNX Operating Cash Flow Growth
Crinetics Pharmaceuticals Inc · Operating Cash Flow Growth
CRNX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-40.94%period ending
CRNX TTM Cash from Operations YoY % (-105.29% → -40.94%)
Year-over-year change
High-resolution chart · PNG
CRNX operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -40.945% | |
| -58.3436% | |
| -67.2443% | |
| -75.0129% | |
| -66.2137% | |
| -46.5807% | |
| -35.8752% | |
| -22.5842% | |
| -12.6234% | |
| -25.3301% | |
| -44.3574% | |
| -58.4099% | |
| -77.7525% | |
| -73.4987% | |
| -30.0458% | |
| -26.0576% | |
| -21.8137% | |
| -17.4625% | |
| -42.8217% | |
| -37.1053% | |
| -34.1301% | |
| -34.7373% | |
| -33.7336% | |
| -52.8799% | |
| -77.7015% | |
| -127.3114% | |
| -138.3524% | |
| -143.9885% | |
| -144.1114% | |
| -116.0133% | |
| -105.2854% |